• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.通过 X 射线晶体学对人肽基精氨酸脱亚氨酶 III 型进行结构表征。
Acta Crystallogr F Struct Biol Commun. 2021 Oct 1;77(Pt 10):334-340. doi: 10.1107/S2053230X21009195. Epub 2021 Sep 21.
2
Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.人肽基精氨酸脱亚氨酶 III 型的结构提供了对底物识别和抑制剂设计的深入了解。
Arch Biochem Biophys. 2021 Sep 15;708:108911. doi: 10.1016/j.abb.2021.108911. Epub 2021 May 7.
3
Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.通过X射线晶体学和小角X射线散射揭示的I型肽基精氨酸脱亚氨酶的单体形式
J Mol Biol. 2016 Jul 31;428(15):3058-73. doi: 10.1016/j.jmb.2016.06.018. Epub 2016 Jul 5.
4
Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin.人类III型肽基精氨酸脱亚氨酶:cDNA的分子克隆与核苷酸序列、重组酶的特性以及在人类皮肤中的免疫组织化学定位
J Invest Dermatol. 2000 Nov;115(5):813-23. doi: 10.1046/j.1523-1747.2000.00131.x.
5
Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.使用 Cl-酰胺、PAD2、PAD3 和 PAD4 同工酶特异性抑制剂在胰腺癌细胞中应用肽基精氨酸脱亚氨酶抑制剂,揭示了 PAD2 和 PAD3 在癌症侵袭和细胞外囊泡特征调节中的作用。
Int J Mol Sci. 2021 Jan 30;22(3):1396. doi: 10.3390/ijms22031396.
6
Targeting Peptidylarginine Deiminase 3 to Efficiently Suppress Herpes Simplex Virus Type 2 Infection.靶向肽基精氨酸脱亚氨酶 3 以有效抑制单纯疱疹病毒 2 型感染。
Int J Mol Sci. 2024 Aug 9;25(16):8709. doi: 10.3390/ijms25168709.
7
Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type III.人Ⅲ型肽基精氨酸脱亚氨酶的结晶及初步X射线晶体学分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Jun 1;68(Pt 6):668-70. doi: 10.1107/S1744309112015333. Epub 2012 May 23.
8
Three isozymes of peptidylarginine deiminase in the chicken: molecular cloning, characterization, and tissue distribution.鸡的三种肽基精氨酸脱亚氨酶同工酶:分子克隆、特征描述和组织分布。
Comp Biochem Physiol B Biochem Mol Biol. 2014 Jan;167:65-73. doi: 10.1016/j.cbpb.2013.10.003. Epub 2013 Oct 23.
9
Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity.人源 VI 型肽基精氨酸脱氨酶(PAD6)的晶体结构揭示了其无活性的原因。
IUCrJ. 2024 May 1;11(Pt 3):395-404. doi: 10.1107/S2052252524002549.
10
Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.蛋白精氨酸脱亚氨酶(PADs):蛋白质瓜氨酸化的生化和化学生物学。
Acc Chem Res. 2019 Mar 19;52(3):818-832. doi: 10.1021/acs.accounts.9b00024. Epub 2019 Mar 7.

引用本文的文献

1
Targeting Peptidylarginine Deiminase 3 to Efficiently Suppress Herpes Simplex Virus Type 2 Infection.靶向肽基精氨酸脱亚氨酶 3 以有效抑制单纯疱疹病毒 2 型感染。
Int J Mol Sci. 2024 Aug 9;25(16):8709. doi: 10.3390/ijms25168709.
2
Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity.人源 VI 型肽基精氨酸脱氨酶(PAD6)的晶体结构揭示了其无活性的原因。
IUCrJ. 2024 May 1;11(Pt 3):395-404. doi: 10.1107/S2052252524002549.
3
Deimination in epidermal barrier and hair formation.表皮屏障和毛发形成中的脱氨基作用。
Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220245. doi: 10.1098/rstb.2022.0245. Epub 2023 Oct 2.
4
Co-expression of PADI isoforms during progenitor differentiation enables functional diversity.PADI 同工型在祖细胞分化过程中的共表达使功能多样化。
Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220451. doi: 10.1098/rstb.2022.0451. Epub 2023 Oct 2.

本文引用的文献

1
Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.蛋白精氨酸脱亚氨酶(PADs):蛋白质瓜氨酸化的生化和化学生物学。
Acc Chem Res. 2019 Mar 19;52(3):818-832. doi: 10.1021/acs.accounts.9b00024. Epub 2019 Mar 7.
2
Variant in Central Centrifugal Cicatricial Alopecia.中央离心性瘢痕性脱发的变异型。
N Engl J Med. 2019 Feb 28;380(9):833-841. doi: 10.1056/NEJMoa1816614. Epub 2019 Feb 13.
3
MolProbity: More and better reference data for improved all-atom structure validation.MolProbity:用于改进全原子结构验证的更多更好的参考数据。
Protein Sci. 2018 Jan;27(1):293-315. doi: 10.1002/pro.3330. Epub 2017 Nov 27.
4
Improvements to the APBS biomolecular solvation software suite.APBS生物分子溶剂化软件套件的改进。
Protein Sci. 2018 Jan;27(1):112-128. doi: 10.1002/pro.3280. Epub 2017 Oct 24.
5
Mutations in Three Genes Encoding Proteins Involved in Hair Shaft Formation Cause Uncombable Hair Syndrome.编码参与毛干形成的蛋白质的三个基因发生突变会导致难梳头发综合征。
Am J Hum Genet. 2016 Dec 1;99(6):1292-1304. doi: 10.1016/j.ajhg.2016.10.004. Epub 2016 Nov 17.
6
Post-translational modified proteins are biomarkers of autoimmune-processes: NETosis and the inflammatory-autoimmunity connection.翻译后修饰蛋白是自身免疫过程的生物标志物:NETosis 和炎症与自身免疫的联系。
Clin Chim Acta. 2017 Jan;464:12-16. doi: 10.1016/j.cca.2016.11.006. Epub 2016 Nov 5.
7
Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.通过X射线晶体学和小角X射线散射揭示的I型肽基精氨酸脱亚氨酶的单体形式
J Mol Biol. 2016 Jul 31;428(15):3058-73. doi: 10.1016/j.jmb.2016.06.018. Epub 2016 Jul 5.
8
Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design.蛋白质精氨酸脱亚氨酶2以有序方式结合钙:对抑制剂设计的启示。
ACS Chem Biol. 2015 Apr 17;10(4):1043-53. doi: 10.1021/cb500933j. Epub 2015 Jan 26.
9
The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities.人源Ⅱ型和Ⅳ型肽基精氨酸脱亚氨酶具有不同的底物特异性。
Biochim Biophys Acta. 2014 Apr;1844(4):829-36. doi: 10.1016/j.bbapap.2014.02.019. Epub 2014 Mar 2.
10
How good are my data and what is the resolution?我的数据质量如何,分辨率是多少?
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14. doi: 10.1107/S0907444913000061. Epub 2013 Jun 13.

通过 X 射线晶体学对人肽基精氨酸脱亚氨酶 III 型进行结构表征。

Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.

机构信息

Department of Biochemistry and Molecular Biology, The Pennsylvania State University, Althouse Laboratory, Science Drive, State College, PA 16801, USA.

School of Biological Sciences, The University of Auckland, 3a Symonds Street, Auckland 1142, New Zealand.

出版信息

Acta Crystallogr F Struct Biol Commun. 2021 Oct 1;77(Pt 10):334-340. doi: 10.1107/S2053230X21009195. Epub 2021 Sep 21.

DOI:10.1107/S2053230X21009195
PMID:34605437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8488854/
Abstract

The Ca-dependent enzyme peptidyl-arginine deiminase type III (PAD3) catalyses the deimination of arginine residues to form citrulline residues in proteins such as keratin, filaggrin and trichohyalin. This is an important post-translation modification that is required for normal hair and skin formation in follicles and keratocytes. The structure of apo human PAD3 was determined by X-ray crystallography to a resolution of 2.8 Å. The structure of PAD3 revealed a similar overall architecture to other PAD isoforms: the N-terminal and middle domains of PAD3 show sequence and structural variety, whereas the sequence and structure of the C-terminal catalytic domain is highly conserved. Structural analysis indicates that PAD3 is a dimer in solution, as is also the case for the PAD2 and PAD4 isoforms but not the PAD1 isoform.

摘要

钙依赖性酶肽基精氨酸脱亚氨酶 III(PAD3)催化精氨酸残基的脱亚氨作用,在角蛋白、板层素和毛透明蛋白等蛋白质中形成瓜氨酸残基。这是一种重要的翻译后修饰,对于毛囊和角质细胞中正常的毛发和皮肤形成是必需的。人源 PAD3 的apo 结构通过 X 射线晶体学解析到 2.8 Å 的分辨率。PAD3 的结构揭示了与其他 PAD 同工型相似的整体结构:PAD3 的 N 端和中间结构域显示出序列和结构的多样性,而 C 端催化结构域的序列和结构高度保守。结构分析表明,PAD3 在溶液中是二聚体,与 PAD2 和 PAD4 同工型的情况相同,但与 PAD1 同工型不同。